Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights.

Ibrahim MM, Abuelmatty AM, Mohamed GH, Nasr MA, Hussein AK, Ebaed MED, Sarhan HA.

Drug Des Devel Ther. 2018 Dec 7;12:4171-4179. doi: 10.2147/DDDT.S181834. eCollection 2018.

2.

Real life Egyptian experience of Daclatasvir plus Sofosbuvir with Ribavirin in naïve difficult to treat HCV patients.

Wahsh EA, Hussein AK, Gomaa AA, Baraka MA, Al-Deen Abead M.

Infect Disord Drug Targets. 2018 Jul 16. doi: 10.2174/1871526518666180716141806. [Epub ahead of print]

PMID:
30009715
3.

Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience.

Al-Kali A, Abou Hussein AK, Patnaik M, Zblewski D, Gangat N, Hashmi S, Elliott M, Hogan W, Litzow M.

Leuk Lymphoma. 2018 Feb 21:1-3. doi: 10.1080/10428194.2018.1436705. [Epub ahead of print] No abstract available.

PMID:
29465270
4.

Extended infusion versus intermittent infusion of imipenem in the treatment of ventilator-associated pneumonia.

Ibrahim MM, Tammam TF, Ebaed MED, Sarhan HA, Gad GF, Hussein AK.

Drug Des Devel Ther. 2017 Sep 6;11:2677-2682. doi: 10.2147/DDDT.S143021. eCollection 2017.

5.

Discovery of peptide ligands through docking and virtual screening at nicotinic acetylcholine receptor homology models.

Leffler AE, Kuryatov A, Zebroski HA, Powell SR, Filipenko P, Hussein AK, Gorson J, Heizmann A, Lyskov S, Tsien RW, Poget SF, Nicke A, Lindstrom J, Rudy B, Bonneau R, Holford M.

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):E8100-E8109. doi: 10.1073/pnas.1703952114. Epub 2017 Sep 5.

6.

Failure of the vascular hypothesis of multiple sclerosis in a rat model of chronic cerebrospinal venous insufficiency.

Zakaria MMA, Mikhael SY, Hussein AKA, El-Din RAS, El-Malak HWA, Hewedi IH, Nadim HS.

Folia Neuropathol. 2017;55(1):49-59. doi: 10.5114/fn.2017.66713.

7.

Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.

M A Fathalla Z, Vangala A, Longman M, Khaled KA, Hussein AK, El-Garhy OH, Alany RG.

Eur J Pharm Biopharm. 2017 May;114:119-134. doi: 10.1016/j.ejpb.2017.01.008. Epub 2017 Jan 24.

PMID:
28126392
8.

Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor.

El-Sayed MM, Hussein AK, Sarhan HA, Mansour HF.

Drug Dev Ind Pharm. 2017 Jun;43(6):902-910. doi: 10.1080/03639045.2016.1272120. Epub 2017 Jan 31.

PMID:
27977311
9.

Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis.

Mady FM, Essa H, El-Ammawi T, Abdelkader H, Hussein AK.

Drug Des Devel Ther. 2016 Mar 10;10:1101-10. doi: 10.2147/DDDT.S103423. eCollection 2016.

10.

Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia.

Elala YC, Lasho TL, Gangat N, Finke C, Barraco D, Haider M, Abou Hussein AK, Hanson CA, Ketterling RP, Pardanani A, Tefferi A.

Am J Hematol. 2016 May;91(5):503-6. doi: 10.1002/ajh.24338. Epub 2016 Apr 4.

11.

Optimisation of microstructured biodegradable finasteride formulation for depot parenteral application.

Ahmed OA, Hussein AK, Mady FM.

J Microencapsul. 2016 May;33(3):229-38. doi: 10.3109/02652048.2016.1144821. Epub 2016 Feb 17.

PMID:
26886073
12.

Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients.

Haider M, Gangat N, Lasho T, Abou Hussein AK, Elala YC, Hanson C, Tefferi A.

Am J Hematol. 2016 Jun;91(4):390-4. doi: 10.1002/ajh.24293.

13.

Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.

Fathalla ZM, Khaled KA, Hussein AK, Alany RG, Vangala A.

Drug Dev Ind Pharm. 2016;42(4):514-24. doi: 10.3109/03639045.2015.1081236. Epub 2015 Sep 25.

PMID:
26407208
14.

Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system.

Sayed EG, Hussein AK, Khaled KA, Ahmed OA.

Drug Des Devel Ther. 2015 Mar 10;9:1427-35. doi: 10.2147/DDDT.S80697. eCollection 2015.

15.

Preparation and evaluation of polyamidoamine dendrimer conjugate with glucuronylglucosyl-β-cyclodextrin (G3) as a novel carrier for siRNA.

Abdelwahab AF, Ohyama A, Higashi T, Motoyama K, Khaled KA, Sarhan HA, Hussein AK, Arima H.

J Drug Target. 2014 Dec;22(10):927-34. doi: 10.3109/1061186X.2014.950663. Epub 2014 Aug 22.

PMID:
25148608
16.

Characterization of alpha-particle tracks in cellulose nitrate LR-115 detectors at various incident energies and angles.

Mheemeed AK, Hussein AKh, Kheder RB.

Appl Radiat Isot. 2013 Sep;79:48-55. doi: 10.1016/j.apradiso.2013.04.020. Epub 2013 Apr 30.

PMID:
23727556
17.
18.

Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.

El-Menshawe SF, Hussein AK.

Pharm Dev Technol. 2013 Jul-Aug;18(4):779-86. doi: 10.3109/10837450.2011.598166. Epub 2011 Sep 14.

PMID:
21913880
19.
20.

Reinfestation in cutaneous leishmaniasis: a new look at predisposing conditions.

Sharquie KE, Najim RA, Hussein AK.

Saudi Med J. 2000 May;21(5):464-7.

PMID:
11500682
21.

Impact of user charges on government health facilities in Tanzania.

Hussein AK, Mujinja PG.

East Afr Med J. 1997 Dec;74(12):751-7.

PMID:
9557416

Supplemental Content

Loading ...
Support Center